Health
MedAlliance Acquired by Cordis for up to USD 1.135 Billion
GENEVA, Switzerland, Oct. 2, 2023 /PRNewswire/ -- Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of$35M and a 2023 upfront closing payment of $200M, together with regulatory achievement milestones of up to$125M and commercial milestones of up ...
ZEISS and Boehringer Ingelheim join forces to develop early detection of eye diseases and prevent vision loss
JENA, Deutschland and INGELHEIM, Deutschland, Oct. 2, 2023 /PRNewswire/ -- ZEISS Medical Technology and Boehringer Ingelheim announce today a long-term strategic collaboration to develop predictive analytics to enable early detection of eye diseases and more personalized treatments to prevent vis...
SIBIONICS to Make Debut at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD)
SHENZHEN, China, Oct. 2, 2023 /PRNewswire/ -- The 59th Annual Meeting of the European Association for the Study of Diabetes (EASD) is set to take place from October 2nd to 6th, 2023, in Hamburg, Germany. Making its debut at this prestigious event, Shenzhen Sibionics Technology Co., Ltd. (hereinaft...
China Review Studio and Chinese Red Cross Foundation Release "Generation Vax" Documentary for Broadcast Internationally
The documentary outlines China's contribution to vaccine science, research, and production since the COVID-19 pandemic and includes a call for science and infectious disease research to be borderless. BEIJING, Oct. 2, 2023 /PRNewswire/ -- China Review Studio, in collaboration with Chinese R...
MedAlliance Acquired by Cordis for USD 1.135 Billion
GENEVA, Oct. 2, 2023 /PRNewswire/ -- Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of$35M and a 2023 upfront closing payment of$200M, together with regulatory achievement milestones of up to$125M and commercial milestones of up to $775M throu...
Rimegepant is Now Available in Hong Kong, the First Market in Asia, for Migraine Management
HONG KONG, Sept. 29, 2023 /PRNewswire/ -- Pfizer announced the availability of Rimegepant inHong Kong, the first market in Asia, a calcitonin gene-related peptide (CGRP) receptor antagonist for migraine management.[1],[2] There are approximately 12.5% of people living with migraine inHong Kong[3]...
#UseHeart movement rallies for change as heart disease continues to claim most lives
GENEVA, Sept. 29, 2023 /PRNewswire/ -- This World Heart Day, the World Heart
Federation (WHF) is urging all sectors and citizens to join forces and take
down cardiovascular disease (CVD) from its "number one killer" position.
Bowtie designed insurance plan for individuals aged 50+ before retirement
HONG KONG, Sept. 29, 2023 /PRNewswire/ -- As individuals in their 50s approach retirement, they not only face the loss of a stable monthly income but also the termination of group medical insurance. Considering the increased risk of illness associated with aging, having adequate coverage becomes ...
Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)
ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. Statistically significant secondary endpoints showed improvements in depressive symptoms and sleep. BNC210 was well-tolerated with a safety prof...
Cutting-edge cancer imaging tool allows doctors to efficiently adapt radiotherapy treatment
First patient treated on radiotherapy system equipped with HyperSight imaging solution at Icon Cancer Centre MELBOURNE, Australia, Sept. 29, 2023 /PRNewswire/ -- An innovative technology that captures high-quality images of a tumor in six seconds is being used to guide cancer treatments for pati...
Academic Conference on "Research on Female Reproductive Health in International Perspective" Successfully Concluded
HONG KONG, Sept. 29, 2023 /PRNewswire/ -- On September 22nd, the academic conference on "Female Reproductive Health Research in International Perspective", organized by Hong Kong Research Institute of Modern Chinese Medicine for Reproductive Anti-aging(HKMCMRA), was successfully concluded in Hong...
Ascletis Announces Positive Interim Data from the Phase IIb Expansion Cohort of ASC22 (Envafolimab) for Chronic Hepatitis B Functional Cure
HANGZHOU and SHAOXING, China, Sept. 29, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces positive interim data from the Phase IIb expansion cohort (the "Expansion Cohort") of subcutaneously administered PD-L1 antibody ASC22 (Envafolimab) for functional cure of ch...
Innovent and IASO Bio Present Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023
82.4% of patients without prior CAR-T achieving Complete Response (CR) or better ROCKVILLE, Md. and SUZHOU, China, Sept. 29, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-qualit...
ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study
SINGAPORE, Sept. 28, 2023 /PRNewswire/ -- ALR Technologies SG Ltd. ("ALRT" or the "Company") (OTCQB: ALRTF), a diabetes management company, announces the patent application titledMethod and System of Monitoring a Diabetes Treatment Plan("Predictive A1c") has been granted in Singapore and has rec...
AIA celebrates the grand opening of "AIA Alta Wellness Haven"
Hong Kong insurance industry's first one-stop wellness realm that integrates science andEast-meets-West philosophy Amplifies AIA's High Net Worth Proposition with the establishment of "AIA Club Alta" HONG KONG, Sept. 28, 2023 /PRNewswire/ -- Following the resounding success of the launch of "A...
PATIENTS SPEAK UP ABOUT KIDNEY DISEASE
COMMUNITY HEALTH CAMPAIGN "LIVE YOUR WAY" LAUNCHES ACROSS SINGAPORE * Life with kidney disease the focus of new public health campaign * Baxter Healthcare and National Kidney Foundation partner for patients SINGAPORE, Sept. 28, 2023 /PRNewswire/ -- Baxter International, a global medtech leade...
ScolioLife® Scoliosis & Spine Correction Clinic: A Beacon of Hope for Patients
~ ScolioLife® Pioneers a Comprehensive and Holistic Approach to Scoliosis
Management ~
SINGAPORE, Sept. 28, 2023 /PRNewswire/ -- Dr Kevin Lau
BIOHK2023 LEAVES A MARK ON BIOTECH COMMUNITY: MUST-KNOW HIGHLIGHTS
HONG KONG, Sept. 28, 2023 /PRNewswire/ -- The journey of BIOHK2023 began with an unforgettable opening ceremony on day one, welcoming theNobel Trust Foundation, Dr. Michael Nobel and delivering a noteworthy speech by Mr. Peter Nobel. BIOHK had the privilege of hosting distinguished doctors, profe...
Antengene To Present Results From Five Studies at 2023 SITC Annual Meeting
SHANGHAI and HONG KONG, Sept. 28, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for canc...
Everest Medicines Announces Approval of XERAVA® in Taiwan for the Treatment of Complicated Intra-Abdominal Infections in Adult Patients
SHANGHAI, Sept. 28, 2023 /PRNewswire/ -- Everest Medicines
Week's Top Stories
Most Reposted
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
[Picked up by 332 media titles]
2025-01-18 03:30Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
[Picked up by 306 media titles]
2025-01-18 17:00RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
[Picked up by 295 media titles]
2025-01-14 21:00HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
[Picked up by 295 media titles]
2025-01-20 14:27ARK Wealth Black and Diamond Client Summit: Enhancing Wealth Allocation Strategies for a New Era
[Picked up by 281 media titles]
2025-01-17 13:37